Home/Filings/4/0001209191-17-055353
4//SEC Filing

Gergel Ivan P. 4

Accession 0001209191-17-055353

CIK 0000906709other

Filed

Oct 2, 8:00 PM ET

Accepted

Oct 3, 6:02 PM ET

Size

15.4 KB

Accession

0001209191-17-055353

Insider Transaction Report

Form 4
Period: 2017-09-29
Gergel Ivan P.
SVP & Chief Medical Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2017-10-02$11.04/sh+56,704$626,01298,279 total
  • Sale

    Common Stock

    2017-09-29$24.04/sh43,296$1,040,83641,575 total
  • Exercise/Conversion

    Common Stock

    2017-09-29$11.04/sh+43,296$477,98884,871 total
  • Sale

    Common Stock

    2017-10-02$24.21/sh56,704$1,372,80441,575 total
  • Exercise/Conversion

    Stock Option

    2017-09-2943,296370,456 total
    Exercise: $11.04Exp: 2022-05-18Common Stock (43,296 underlying)
  • Exercise/Conversion

    Stock Option

    2017-10-0256,704313,752 total
    Exercise: $11.04Exp: 2022-05-18Common Stock (56,704 underlying)
Footnotes (4)
  • [F1]This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  • [F2]This transaction was executed in multiple trades at prices ranging from $24.04 to $24.06. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
  • [F3]This transaction was executed in multiple trades at prices ranging from $24.04 to $24.46. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
  • [F4]The stock option pursuant to this transaction vests as follows: 25% of the shares subject to the option vested on May 19, 2015 and the remaining 75% of the shares vest in equal monthly installments over the three-year period thereafter based on the Reporting Person's continuous service to the issuer.

Issuer

NEKTAR THERAPEUTICS

CIK 0000906709

Entity typeother

Related Parties

1
  • filerCIK 0001328288

Filing Metadata

Form type
4
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 6:02 PM ET
Size
15.4 KB